Abstract
The role of lymph node dissection in the management of papillary thyroid carcinoma (PTC) remains controversial given the overall excellent long-term survival and lack of documented survival benefit with prophylactic lymphadenectomy. When one considers removal of subclinical (nonpalpable) metastases, particularly in the central compartment, questions arise concerning the ability of available imaging studies to localize disease adequately for a curative surgical intent. Although computed tomography (CT) is routinely used to guide surgical planning in head and neck squamous cell carcinoma (HNSCC), its utility in PTC is less established. This is reflected in the 2006 American Thyroid Association Guidelines Taskforce recommendation in favor of preoperative imaging with ultrasonography.1 The taskforce recommended not using preoperative imaging with CT, noting that its sensitivity in the setting of PTC remains unknown. Despite the lack of data regarding its efficacy, CT offers several potential advantages over ultrasonography. Computed tomography provides static anatomical information in a fully retrievable format. This facilitates subsequent intraoperative correlation with surgical landmarks. The acquisition of images is also less operator dependent compared with ultrasonography, promoting reproducibility. Computed tomography may excel in specific settings, such as patients with a thick neck or for visualization of the low paratracheal nodes, which may be obscured by the sternum or tracheal air shadow when ultrasonography is used. In addition, the anatomical levels that form the basis of the current surgical technique have been formalized using CT-based criteria,2 which promotes consistent communication between the radiologist and the surgeon in regard to disease location. Disadvantages of CT include increased cost and radiation exposure.